is brello tirzepatide safe Health Review 2025: GLP-1 Telehealth Weight Loss Program With Semaglutide, Tirzepatide, and Personalized Coaching Brello Health | Connect with

Diabetes & Metabolism, 46 ,

For example, one analysis found that patients taking a GLP-1 drug had a 3.67 times higher risk of gastroparesis compared to patients who took bupropion-naltrexone, a different weight-loss drug

For example, the SELECT trial showed a 20% improvement in major cardiovascular events (i.e., heart attacks, strokes, and deaths from those cases) in adults on weekly semaglutide who were overweight or obese (without diabetes) and with preexisting cardiovascular disease, as well as an improvement in all-cause mortality of 19%

Aim for 400 to 600 mg daily of magnesium glycinate or citrate, which are well-absorbed forms that also support GI motility